Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
1 other identifier
observational
992
1 country
1
Brief Summary
The purpose of this study is to assess populations in Thailand at high risk for HIV-1 infection for potential efficacy trials of candidate HIV vaccines to include:
- 1.assess incidence of HIV-1 and volunteer retention
- 2.describe early viral load and CD4 counts
- 3.assess participant willingness to participate in HIV vaccine efficacy trials and other HIV prevention trials
- 4.describe volunteer risk behavior
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 7, 2008
CompletedFirst Posted
Study publicly available on registry
July 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedMay 28, 2015
May 1, 2015
1.4 years
July 7, 2008
May 27, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
number of HIV-1 infections per 100 person-years
5 years
Lost to follow-up on an annual basis (10% or better)
5 years
Post-infection viral load and CD4 count
5 years
Willingness to participate in HIV vaccine and prevention trials
5 years
Risk behavior by questionnaire
5 years
Secondary Outcomes (2)
HIV-1 prevalence
5 years
HIV-1 genotype distribution
5 years
Eligibility Criteria
Population in Thailand who are seeking HIV counseling and testing at TRCARC
You may qualify if:
- Man or woman aged 18-50 years
- Willing to provide location or contact information and allow contact
- Thai citizenship as identified by Thai National Identification card
- Ability and willingness to provide consent
- Availability for follow-up for the planned study duration
You may not qualify if:
- Persons who have a history of a medical or psychiatric disorder, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent
- Persons who are known to be HIV-positive
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Thai Red Cross AIDS Research Centre
Bangkok, Bangkok, 10330, Thailand
Biospecimen
Plasma, CD4, HIV-RNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nittay - Phanuphak, MD.
The Thai Red Cross AIDS Research Centre, Bangkok, Thailand
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jintanat Ananworanich
Study Record Dates
First Submitted
July 7, 2008
First Posted
July 11, 2008
Study Start
July 1, 2008
Primary Completion
December 1, 2009
Study Completion
June 1, 2010
Last Updated
May 28, 2015
Record last verified: 2015-05